BNTC · Forms 3, 4, 5
Insider trades at Benitec Biopharma Inc.
No open-market insider buys or sells at Benitec Biopharma Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Benitec Biopharma Inc. (BNTC) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Benitec Biopharma Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| J Kevin Buchi | Director | Gift | 51,813 | Form 4 | |||
| David Matthew Friedman | Director | Options or other derivatives | Form 4 | ||||
| David Matthew Friedman | Director | Became an insider (Form 3) | Form 3 | ||||
| Sharon Mates | Director | Options or other derivatives | Form 4 | ||||
| SUVRETTA CAPITAL MANAGEMENT, LLC | Director | Buy | 65,800 | $13.44 | $884K | Form 4 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Director | Buy | 11,587 | $13.44 | $156K | Form 4 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Director | Buy | 14,320 | $13.10 | $188K | Form 4 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Director | Buy | 2,516 | $13.10 | $33K | Form 4 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Director | Buy | 42,600 | $12.85 | $547K | Form 4 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Director | Buy | 7,400 | $12.85 | $95K | Form 4 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Director | Buy | 16,650 | $12.08 | $201K | Form 4 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Director | Buy | 2,892 | $12.08 | $35K | Form 4 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Director | Buy | 13,950 | $11.48 | $160K | Form 4 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Director | Buy | 2,434 | $11.48 | $28K | Form 4 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Director | Buy | 8,700 | $11.24 | $98K | Form 4 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Director | Buy | 1,515 | $11.24 | $17K | Form 4 | |
| Sharon Mates | Director | Options or other derivatives | Form 4 | ||||
| Kishan Mehta | Director | Options or other derivatives | Form 4 | ||||
| Edward F Smith | Director | Options or other derivatives | Form 4 | ||||
| Peter Francis | Director | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.